
Radian Group (RDN) Earnings Dates & Reports
Radian Group (RDN) Most Recent Earnings
Report Date
Period EndingQ3 2025
Est. EPS$0.98
Actual EPS$1.15
EarningsBeat
Radian Group (RDN) Earnings
View the latest Radian Group (RDN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Radian Group (RDN)
Order type
Buy in
Order amount
Est. shares
0 shares
Radian Group (RDN) Earnings per Share (EPS) History
Signup for full accessBrowse free
Radian Group (RDN) Latest Earnings
The value each RDN share was expected to gain vs. the value each share gained.
Radian Group (RDN) reported its most recent earnings on for Q3 2025, posting earnings per share (EPS) of $1.15. This exceeded analysts' expectations of $0.98 by 17.35%, marking a Beat.
For comparison, Radian Group reported EPS of $1.03 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $1.09.
Radian Group (RDN) Earnings History
Radian Group (RDN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Radian Group’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Radian Group (RDN) Earnings FAQs
Radian Group (RDN) last reported earnings on Nov 5, 2025 for Q3 2025, posting an EPS of $1.15, which Beat the estimate of $0.98 by 17.35%.
For Q3 2025, Radian Group (RDN) reported an EPS of $1.15, exceeding analysts' estimate of $0.98 by 17.35%.
For Q3 2025, Radian Group (RDN) Beat expectations with an actual EPS of $1.15 vs. an estimated EPS of $0.98.
Following the last earnings report on Nov 5, 2025, Radian Group (RDN)'s stock price moved — from — to —.
The next Radian Group (RDN) earnings call is scheduled for Feb. 4, 2026, where executives will discuss financial results and outlook.